Back

Watch Compare

Zhengye Biotechnology Holding Ltd

Data quality: 100%

ZYBT

Nasdaq Manufacturing Chemicals

$0.98

▲ $0.02 (2.56%)

Mkt Cap: 46.44 M

Price

$0.98

Mkt Cap

46.44 M

Day Range

$0.97 — $0.98

52-Week Range

$0.68 — $14.30

Volume

8,562

Open $0.97

50D / 200D Avg

$0.88

11.25% above

50D / 200D Avg

$3.53

72.20% below

Quick Summary

Key Takeaways

ROE of 3.98% is below average

Debt/Equity of 0.30 — conservative balance sheet

Generating 3.76 M in free cash flow

Cash machine — converts 242.71% of earnings into free cash flow

Capital efficient — spends only 7.29% of revenue on capex

ROIC of 3.56% — low return on invested capital

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

3.98%

Above sector avg (-53.47%)

ROIC3.56%

Net Margin6.07%

Op. Margin8.82%

Safety

Debt / Equity

0.30

Below sector avg (0.31)

Current Ratio1.31

Interest Coverage4.06

Valuation

PE (TTM)

29.96

Above sector avg (-1.47)

P/B Ratio1.19

EV/EBITDA10.02

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	30.0	-1.5
P/B	1.2	1.6
ROE %	4.0	-53.5
Net Margin %	6.1	-41.5
Rev Growth 5Y %	—	1.8
D/E	0.3	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	25.53 M	Net Income (TTM)	1.55 M
ROE	3.98%	ROA	2.29%
Gross Margin	48.99%	Operating Margin	8.82%
Net Margin	6.07%	Free Cash Flow (TTM)	3.76 M
ROIC	3.56%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.30	Current Ratio	1.31
Interest Coverage	4.06	Asset Turnover	0.38
Working Capital	5.71 M	Tangible Book Value	36.87 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	29.96	Forward P/E	N/A
P/B Ratio	1.19	P/S Ratio	1.82
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	10.02	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	8.10%
Market Cap	46.44 M	Enterprise Value	55.74 M
Per Share
EPS (Diluted TTM)	0.03	Revenue / Share	0.54
FCF / Share	0.08	OCF / Share	0.12
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	7.29%	FCF Conversion	242.71%
SBC-Adj. FCF	N/A	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2024
Revenue	25.53 M
Net Income	1.55 M
EPS (Diluted)	0.03
Gross Profit	12.51 M
Operating Income	2.25 M
EBITDA	—
R&D Expenses	1.75 M
SG&A Expenses	—
D&A	3.31 M
Interest Expense	554,000.0
Income Tax	127,000.0

Balance Sheet

Annual, most recent first

Metric	FY2024
Total Assets	67.58 M
Total Liabilities	19.28 M
Shareholders' Equity	38.90 M
Total Debt	11.84 M
Cash & Equivalents	2.55 M
Current Assets	24.33 M
Current Liabilities	18.62 M